ESR1 and breast cancer: Because most of the studies in breast cancer involved mixed cohorts that were largely comprised of ER+ cases, the association between FoxP3+ Tregs and good prognosis in ER– cases may have been obscured by a negative prognostic relationship among ER+ tumors.